Diplomat Specialty Pharmacy at Association of Nurses in AIDS Care (ANAC) Conference

Join Diplomat’s HIV Navigator Team November 19-22 , 2009 for ANAC ’s 22nd Annual Conference at the Hyatt Jacksonville Riverfront in Jacksonville, Florida.   Learn about Diplomat’s HIV personalized medication program and how we help prescribers and patients gain access to  meds and improve patient adherence rates.

This year’s conference theme centers around building capacity through collaboration. The conference will include information about HIV care and treatment relevant to nurses and health professionals new to HIV care treatment, as well as those who are experienced, and/or practice at advanced levels. Jacksonville’s warm climate and proximity to the beach make it a great place for Conference and fun!

more info about the ANAC Conference : http://www.nursesinaidscare.org/i4a/pages/index.cfm?

For more information about Diplomat’s HIV Patient Care Program: http://diplomatpharmacy.com/patient_services/hiv_aids

H1N1 Vaccine Delays Blamed on Production Challenges

The Centers for Disease Control and Prevention (CDC) has ordered about 250 million doses of H1N1 vaccine for the 2009-2010 flu season and expected about 29 million doses to be available by the end of October 2009. To date, only 14 million doses have been produced and only 11 million doses have been distributed in the United States.

Most of the delay has been attributed to development of the vaccine and filling vials within the production facilities of the manufacturers that are producing the vaccine. There was also a delay in approval of the vaccine by regulators before it could be manufactured. One of the manufacturers, Novartis AG, has reported that their vaccine may not be available until the first quarter of 2010 due to production issues. Novartis AG will provide continued status reports on the availability of their vaccine.

More info at www.cdc.gov;

 

Diplomat Specialty Pharmacy’s Susan Pennell Completes Anti-Aging Fellowship, Receives Health Practitioner Diplomate

Swartz Creek, Mich., Oct 15, 2009  – Diplomat Specialty Pharmacy announced today that after successfully completing the fellowship program from the American Academy of Anti-Aging Medicine, Susan Pennell Pharmacy Director at Diplomat Specialty’s Flint location has been awarded the Designation of Health Practitioner Diplomate. 

The fellowship included Anti-Aging, Restorative and Functional Medicine.  Anti-aging medicine focuses on early detection, prevention, treatment and reversal of age-related decline.  Regenerative medicine optimizes the body’s endogenous mechanisms of self repair.  Functional medicine looks at illness and promotes wellness by focusing on the biochemical pathways and restoring balance.

 “Having an anti-aging expert such as Sue on staff allows Diplomat to meet a growing need,” said Jeff Rowe, Sr. Vice President of Operations for Diplomat Specialty Pharmacy. “With an increasing number of baby boomers seeking out anti-aging therapies, Diplomat is in a position to offer the possible care and advice. Our patients will definitely benefit from Sue’s clinical experience and fellowship training.”

Pennell is a Registered Pharmacist and Certified Clinical Nutritionist. She provides wellness consultations to women and men of all ages. She can be contacted at: spennell@diplomatpharmacy.com

Diplomat Specialty Pharmacy Selected As Exclusive Specialty Pharmacy For Inland Empire Health Plan Of California

Swartz Creek, Mich, October 20, 2009 – Diplomat Specialty Pharmacy announced today that Inland Empire Health Plan (IEHP) has chosen Diplomat to be its exclusive provider of Specialty Disease Management services for IEHP members with Rheumatoid Arthritis, Psoriasis, and Crohn’s Disease.  Diplomat will provide dispensing and patient care services for these disease states for IEHP members effective November 1, 2009. 

 

“We were selected by IEHP because we will improve services to their members. Our Disease Management Programs are designed specifically to ease the burdens patients face in the management of their challenging conditions,” stated Diplomat Specialty Pharmacy’s President, Phil Hagerman. “Working closely with patients and their physicians we can keep patients more adherent on their medication therapies and that translates into healthier patients. We will be using our new Southern California Distribution center to service our IEHP patients.”

 

“Diplomat Specialty Pharmacy has one of the best Disease Management Programs we have seen among the industry,” stated Dr. William Henning, Chief Medical Officer for IEHP. “IEHP sets a very high standard when selecting a Disease Management Program.  We want to make sure our Members understand their disease states, the medications that they use, and help them to get better through a structured educational/monitoring program.  We believe Diplomat will help us deliver high quality patient care and improve patients’ quality of life through its innovative and flexible program.” 

About IEHP

IEHP, Inland Empire Health Plan, a Knox-Keene licensed Health Plan located in San Bernardino, California, is a not-for-profit public agency. The IEHP service area includes San Bernardino and Riverside Counties and currently serves over 420,000 Members in the following Programs: Medi-Cal, Healthy Families, Healthy Kids, and a Medicare Advantage Special Needs Program. 

 

 

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation’s largest privately held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions.  Key programs include:  Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s, Hemophilia, Growth Hormone and Psoriasis.  Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding.  The company also specializes in Disease Management programs for Chronic Kidney Disease patients.  With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; and a new location in San Bernardino California; Diplomat services the specialty pharmacy needs of patients and physicians nationwide. 

For more information contact:
Kathy Karns
kkarns@diplomatpharmacy.com
810-720-4452

Protect Your Kidneys: Another Reason to Lose Weight

-from the National Kidney Foundation

Many Americans are overweight and they probably know being overweight causes health problems. They may not know that being overweight is not good for the kidneys. Excess weight increases the risk of diabetes and hypertension, the two major causes of chronic kidney disease.

Research by the National Kidney Foundation screening program found that many people who attended kidney disease screenings were overweight or obese. In fact, nearly half of those who attended were overweight or obese. The National Kidney Foundation has a community-based health-screening program called KEEP (Kidney Early Evaluation Program). It looks at the health of people 18 years and older with diabetes, hypertension, or family history of these conditions or kidney disease.

The National Kidney Foundation KEEP program has screened thousands of participants. More than one in four people who came to the screenings were found to have chronic kidney disease. Early identification of people at risk is important so chronic kidney disease can be prevented. If people lower their blood pressure and blood sugar if the levels are too high, they can help their kidneys.

Doctors are concerned not only with how much fat a person has, but also where the fat is located on the body. Women typically collect fat around their hips, giving them a pear shape. Men usually build up fat around their bellies giving them more of an apple shape. If you carry fat mainly around your waist, you are more likely to develop obesity-related health problems. Women whose waists measure more than 35 inches or men whose waists measure more than 40 inches have a higher health risk because of their fat distribution.

The risk of kidney disease is higher in people who carry their weight around the middle. In fact, the waist-to-hip ratio (apple-shaped body) is now considered to be a risk factor for chronic kidney disease because it increases the risk of diabetes and hypertension. Having an “apple” shape also predicts heart problems in people who already have chronic kidney disease.

Maintaining a healthy body weight is important for your health and for the health of your kidneys!

If you have questions or need help fighting  Chronic Kidney Disease call Diplomat Specialty Pharmacy at 1.877.977.9119

or help is a click away at:http://www.diplomatpharmacy.com/patient_services/chronic_kidney_disease

Diplomat Specialty Pharmacy Now Provides New FDA Approved Stelara™ for Moderate to Severe Plaque Psoriasis

Diplomat Specialty Pharmacy is now providing  Stelara(tm) (ustekinumab) for the treatment of adults with moderate to severe plaque psoriasis.  At no cost to the patient or health care provider- Diplomat will:

  • Initiate and manage the entire Insurance Prior Authorization process
  • Assist patients with all insurance issues including Appeals & Denials
  • Seek financial assistance from any available Patient Assistance Fund
  • Coordinate Medicare Donut Hole Assistance
  • Coordinate Stelara(tm) Support Co-Pay Assistance Cards for all eligible patients
  • Coordinate delivery of Stelara(tm) with each office visit

Please call a Diplomat Psoriasis Care Coordinator  at 1.866.311.9966 for more information.

For more information go to our website: http://www.diplomatpharmacy.com/patient_services/psoriasis;

H1N1 Flu Vaccinations May Begin in 3 weeks in U.S.

 

The Centers for Disease Control and Prevention (CDC) reported that the H1N1 vaccine my be

available in the United States by the end of September 2009 with initial vaccinations of the population

beginning the first week of October 2009. Initial tests have identified that a single vaccination

may be effective against H1N1 within 8 to 10 days.

The CDC also reported that the vast majority of the population should be able to receive H1N1

vaccination by mid-October 2009. There are several pharmaceutical manufacturers currently developing

the H1N1 vaccine.

For more information visit http://www.cdc.gov/h1n1flu;

 

 

FDA Approves H1N1 Vaccines

The FDA on Tuesday approved vaccines designed to protect against the H1N1 flu virus. The U.S. has spent more than $1 billion to purchase and administer a total of 195 million H1N1 vaccine doses being made by 5 companies.

About 40 million to 50 million vaccine doses will be available by the middle of next month and will be distributed to each state’s health department.

At  Diplomat Specialty Pharmacy we will provide vaccines at our  location in Grand Rapids, MI . No appointment is necessary.  For more information: please call  616.356.1800 and ask for Shannon.

read entire article from the Wall Street Journal here: http://online.wsj.com/article/SB10001424052970203917304574415142309586868.html?mod=dist_smartbrief

AIDS Walk 2009

7 Walks – 2 Weekends – 1 Step!

Diplomat is a sponsor of AIDS WALK Michigan.
The Walks are Saturday or Sunday, September 26-27 and October 3-4.
This event takes place at 7 locations all over the great state of Michigan.   So get walking. Your first step is right here http://www.aidswalkmichigan.org

To find a Walk in your city check  http://www.aidswalk.net/awdirectory.html

News You Can Use: How To Qualify For Medication Co-Pay Assistance

What Patients Should Know About Qualifying For Co-Pay Assistance Through A Foundation

by Sandy Hope- Chronic Disease Fund Coordinator- Diplomat Specialty Pharmacy

In this article:

  • Co-pay award is available for one year or until the amount is exhausted
  •  Diplomat recently expanded our  funding department to assist as many patients as possible
  • In addition to being diagnosis specific some foundations are diagnosis and drug specific
  • Proof of income is a prerequisite and is generally satisfied through the submission of the patient’s most recent federal tax return
  • The foundations are not designed to cover the total cost of the drug, but rather to cover the patient’s co-pay amount

 

It is a blessing to know there are several well established foundations dedicated to helping patients with the co-pay cost of their medicines.  If qualified, the foundation provides a specified amount to be applied against a patient’s co-pay cost.  This award is available for one year or until the amount is exhausted, whichever occurs first.  The amount provided is most often based on the patient’s diagnosis.   At Diplomat we put a lot of effort toward helping our patients obtain co-pay assistance through these foundations.  In fact, we have recently expanded our funding department created for the purpose of reaching out to as many patients as possible to help them get the assistance they need to afford their medicine(s).

Each foundation has designated disease states or medical conditions that they support.  Some diagnoses are represented by several foundations where others are only supported by one or two foundations making it more difficult to get funding for some medical conditions.  We are continuously seeking out additional foundations and resources for our patients.

In addition to being diagnosis specific some foundations are diagnosis and drug specific.  This means in order to qualify for funding the diagnosis and drug prescribed must both be supported by the foundation.    As part of the application process the prescribing physician is required to complete and sign a section of the foundation’s application verifying the diagnosis and drug(s) prescribed.

Other guidelines of the foundations are similar in regard to the information each uses to determine a patient’s qualification.  For instance, most consider the household size and income and have predetermined income schedules as part of their financial guidelines.  To qualify, the household income cannot exceed the guidelines of the respective foundation.  Proof of income is a prerequisite and is generally satisfied through the submission of the patient’s most recent federal tax return.  If the patient is not required to file taxes, then he/she is asked to submit alternate documentation such as a copy of his/her (and spouse’s if applicable) social security award letter, a bank statement showing income deposits, and a pension statement if applicable.  The documents are to be submitted along with the foundation’s respective application.

Another key factor in determining eligibility is the patient’s insurance coverage.  The foundations are not designed to cover the total cost of the drug, but rather to cover the patient’s co-pay amount.  For this reason patients are required to have Rx coverage or medical insurance that participates in the prescription cost.  The foundations are aware of the pitfalls of Part D coverage and the gap period (donut-hole) a patient faces when taking costly medicines.  Many foundations award enough to get patients through this period, but yet others do not and patients must seek additional funding.  As part of the application process, the patient is required to provide copies of his/her insurance cards (front and back) for insurance verification purposes. 

The above mentioned criteria (diagnosis, drug, household size and income, and insurance coverage) are the most common factors used by foundations to determine eligibility, but are not inclusive of the requirements established by each separate foundation.   Our trained staff will help patients determine which foundation is best for them based on their particular circumstance.

Diplomat has also recently made enhancements to its website and the NeedyMed website now making it possible for patients, physicians or their staff, and others to complete an online application to Diplomat asking our help in seeking co-pay assistance.  When completing this application the following information will be required:  Patient’s Name, Date of Birth, Address, Social Security Number (optional) , Physician’s Name and Phone Number, Diagnosis, Drug(s) Prescribed, Household Size and Income, and Medical and Rx Insurance Information.   The application can be accessed by going to https://www.diplomatpharmacy.com/funding.  Upon receipt of the application, a Patient Care Coordinator will contact the submitter of the application to further qualify the patient for co-pay assistance through one of the foundations.